pre-ipo
Stage
About
MindMed is a clinical-stage biotech company developing psychedelic-inspired medicines and therapies to treat mental health disorders such as anxiety, depression, PTSD, and autism spectrum disorder through novel formulations of LSD, MDMA, and related compounds.
Explore MindMed's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.